Evaluation of Immediate-Release Viloxazine in Adults With ADHD

Clinical trial NCT01107496 · COMPLETED

Trial details

NCT number: NCT01107496
Sponsor: Supernus Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Attention-Deficit/Hyperactivity Disorder (ADHD)

Start date: 2010-06-01
Primary completion: 2010-12-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.